Cargando…
Effective DNA damage response after acute but not chronic immune challenge: SARS-CoV-2 vaccine versus Systemic Lupus Erythematosus
Whether and how an acute immune challenge may affect DNA Damage Response (DDR) is unknown. By studying vaccinations against Influenza and SARS-CoV-2 (mRNA-based) we found acute increases of type-I interferon-inducible gene expression, oxidative stress and DNA damage accumulation in blood mononuclear...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8171000/ https://www.ncbi.nlm.nih.gov/pubmed/34089859 http://dx.doi.org/10.1016/j.clim.2021.108765 |
_version_ | 1783702350197686272 |
---|---|
author | Ntouros, Panagiotis A. Vlachogiannis, Nikolaos I. Pappa, Maria Nezos, Adrianos Mavragani, Clio P. Tektonidou, Maria G. Souliotis, Vassilis L. Sfikakis, Petros P. |
author_facet | Ntouros, Panagiotis A. Vlachogiannis, Nikolaos I. Pappa, Maria Nezos, Adrianos Mavragani, Clio P. Tektonidou, Maria G. Souliotis, Vassilis L. Sfikakis, Petros P. |
author_sort | Ntouros, Panagiotis A. |
collection | PubMed |
description | Whether and how an acute immune challenge may affect DNA Damage Response (DDR) is unknown. By studying vaccinations against Influenza and SARS-CoV-2 (mRNA-based) we found acute increases of type-I interferon-inducible gene expression, oxidative stress and DNA damage accumulation in blood mononuclear cells of 9 healthy controls, coupled with effective anti-SARS-CoV-2 neutralizing antibody production in all. Increased DNA damage after SARS-CoV-2 vaccine, partly due to increased oxidative stress, was transient, whereas the inherent DNA repair capacity was found intact. In contrast, in 26 patients with Systemic Lupus Erythematosus, who served as controls in the context of chronic immune activation, we validated increased DNA damage accumulation, increased type-I interferon-inducible gene expression and induction of oxidative stress, however aberrant DDR was associated with deficiencies in nucleotide excision repair pathways. These results indicate that acute immune challenge can indeed activate DDR pathways, whereas, contrary to chronic immune challenge, successful repair of DNA lesions occurs. |
format | Online Article Text |
id | pubmed-8171000 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Elsevier Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-81710002021-06-02 Effective DNA damage response after acute but not chronic immune challenge: SARS-CoV-2 vaccine versus Systemic Lupus Erythematosus Ntouros, Panagiotis A. Vlachogiannis, Nikolaos I. Pappa, Maria Nezos, Adrianos Mavragani, Clio P. Tektonidou, Maria G. Souliotis, Vassilis L. Sfikakis, Petros P. Clin Immunol Full Length Article Whether and how an acute immune challenge may affect DNA Damage Response (DDR) is unknown. By studying vaccinations against Influenza and SARS-CoV-2 (mRNA-based) we found acute increases of type-I interferon-inducible gene expression, oxidative stress and DNA damage accumulation in blood mononuclear cells of 9 healthy controls, coupled with effective anti-SARS-CoV-2 neutralizing antibody production in all. Increased DNA damage after SARS-CoV-2 vaccine, partly due to increased oxidative stress, was transient, whereas the inherent DNA repair capacity was found intact. In contrast, in 26 patients with Systemic Lupus Erythematosus, who served as controls in the context of chronic immune activation, we validated increased DNA damage accumulation, increased type-I interferon-inducible gene expression and induction of oxidative stress, however aberrant DDR was associated with deficiencies in nucleotide excision repair pathways. These results indicate that acute immune challenge can indeed activate DDR pathways, whereas, contrary to chronic immune challenge, successful repair of DNA lesions occurs. Elsevier Inc. 2021-08 2021-06-02 /pmc/articles/PMC8171000/ /pubmed/34089859 http://dx.doi.org/10.1016/j.clim.2021.108765 Text en © 2021 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Full Length Article Ntouros, Panagiotis A. Vlachogiannis, Nikolaos I. Pappa, Maria Nezos, Adrianos Mavragani, Clio P. Tektonidou, Maria G. Souliotis, Vassilis L. Sfikakis, Petros P. Effective DNA damage response after acute but not chronic immune challenge: SARS-CoV-2 vaccine versus Systemic Lupus Erythematosus |
title | Effective DNA damage response after acute but not chronic immune challenge: SARS-CoV-2 vaccine versus Systemic Lupus Erythematosus |
title_full | Effective DNA damage response after acute but not chronic immune challenge: SARS-CoV-2 vaccine versus Systemic Lupus Erythematosus |
title_fullStr | Effective DNA damage response after acute but not chronic immune challenge: SARS-CoV-2 vaccine versus Systemic Lupus Erythematosus |
title_full_unstemmed | Effective DNA damage response after acute but not chronic immune challenge: SARS-CoV-2 vaccine versus Systemic Lupus Erythematosus |
title_short | Effective DNA damage response after acute but not chronic immune challenge: SARS-CoV-2 vaccine versus Systemic Lupus Erythematosus |
title_sort | effective dna damage response after acute but not chronic immune challenge: sars-cov-2 vaccine versus systemic lupus erythematosus |
topic | Full Length Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8171000/ https://www.ncbi.nlm.nih.gov/pubmed/34089859 http://dx.doi.org/10.1016/j.clim.2021.108765 |
work_keys_str_mv | AT ntourospanagiotisa effectivednadamageresponseafteracutebutnotchronicimmunechallengesarscov2vaccineversussystemiclupuserythematosus AT vlachogiannisnikolaosi effectivednadamageresponseafteracutebutnotchronicimmunechallengesarscov2vaccineversussystemiclupuserythematosus AT pappamaria effectivednadamageresponseafteracutebutnotchronicimmunechallengesarscov2vaccineversussystemiclupuserythematosus AT nezosadrianos effectivednadamageresponseafteracutebutnotchronicimmunechallengesarscov2vaccineversussystemiclupuserythematosus AT mavraganicliop effectivednadamageresponseafteracutebutnotchronicimmunechallengesarscov2vaccineversussystemiclupuserythematosus AT tektonidoumariag effectivednadamageresponseafteracutebutnotchronicimmunechallengesarscov2vaccineversussystemiclupuserythematosus AT souliotisvassilisl effectivednadamageresponseafteracutebutnotchronicimmunechallengesarscov2vaccineversussystemiclupuserythematosus AT sfikakispetrosp effectivednadamageresponseafteracutebutnotchronicimmunechallengesarscov2vaccineversussystemiclupuserythematosus |